ICU Medical, Inc.

NasdaqGS:ICUI Rapport sur les actions

Capitalisation boursière : US$4.1b

ICU Medical Gestion

Gestion contrôle des critères 3/4

Le PDG ICU Medical est Vivek Jain, nommé en Feb2014, a un mandat de 10.75 ans. La rémunération annuelle totale est $ 6.81M, composée du salaire de 11.4% et des bonus 88.6%, y compris les actions et options de la société. détient directement 0.79% des actions de la société, d'une valeur de $ 32.39M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 6.8 ans et 6.8 ans.

Informations clés

Vivek Jain

Directeur général

US$6.8m

Rémunération totale

Pourcentage du salaire du PDG11.4%
Durée du mandat du directeur général10.8yrs
Propriété du PDG0.8%
Durée moyenne d'occupation des postes de direction6.8yrs
Durée moyenne du mandat des membres du conseil d'administration6.8yrs

Mises à jour récentes de la gestion

Recent updates

ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets

Nov 15
ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Lifting Their Price Targets

A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Oct 01
A Look At The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry

Aug 18
ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Bounce 30% But Its Business Still Trails The Industry

ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly

Aug 07
ICU Medical (NASDAQ:ICUI) Seems To Use Debt Quite Sensibly

ICU Medical - Stabilization Is In Sight, But The Road Back Is Difficult

Jun 27

ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Jun 23
ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price

Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

May 09
Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package

Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

Apr 26
Why Investors Shouldn't Be Surprised By ICU Medical, Inc.'s (NASDAQ:ICUI) Low P/S

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Mar 31
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

Jan 31
Is ICU Medical, Inc. (NASDAQ:ICUI) Trading At A 44% Discount?

ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

Jan 04
ICU Medical, Inc.'s (NASDAQ:ICUI) Shares Lagging The Industry But So Is The Business

These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Oct 28
These 4 Measures Indicate That ICU Medical (NASDAQ:ICUI) Is Using Debt Extensively

Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

Oct 07
Is There An Opportunity With ICU Medical, Inc.'s (NASDAQ:ICUI) 37% Undervaluation?

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jul 19
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Jun 22
Calculating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

Apr 03
Here's Why ICU Medical (NASDAQ:ICUI) Can Afford Some Debt

Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

Feb 27
Estimating The Intrinsic Value Of ICU Medical, Inc. (NASDAQ:ICUI)

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Dec 07
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Sep 07
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical Hit Hard As Smiths Medical Needs Significant TLC

Aug 20

ICU Medical Non-GAAP EPS of $1.37 misses by $0.29, revenue of $561M misses by $3.1M

Aug 08

FDA labels ICU Medical unit's April recall of syringe infusion pumps as most serious

Jul 20

ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

Jun 08
ICU Medical (NASDAQ:ICUI) Takes On Some Risk With Its Use Of Debt

ICU Medical: There Is Still Upside Here As Management Goes Big To Drive Value

Mar 25

Analyse de la rémunération des PDG

Comment la rémunération de Vivek Jain a-t-elle évolué par rapport aux bénéfices de ICU Medical?
DateRémunération totaleSalaireBénéfices de l'entreprise
Sep 30 2024n/an/a

-US$111m

Jun 30 2024n/an/a

-US$71m

Mar 31 2024n/an/a

-US$59m

Dec 31 2023US$7mUS$775k

-US$30m

Sep 30 2023n/an/a

-US$28m

Jun 30 2023n/an/a

-US$48m

Mar 31 2023n/an/a

-US$46m

Dec 31 2022US$6mUS$756k

-US$74m

Sep 30 2022n/an/a

-US$39m

Jun 30 2022n/an/a

US$5m

Mar 31 2022n/an/a

US$41m

Dec 31 2021US$5mUS$650k

US$103m

Sep 30 2021n/an/a

US$109m

Jun 30 2021n/an/a

US$103m

Mar 31 2021n/an/a

US$94m

Dec 31 2020US$3mUS$650k

US$87m

Sep 30 2020n/an/a

US$81m

Jun 30 2020n/an/a

US$83m

Mar 31 2020n/an/a

US$87m

Dec 31 2019US$3mUS$650k

US$101m

Sep 30 2019n/an/a

US$73m

Jun 30 2019n/an/a

US$47m

Mar 31 2019n/an/a

US$55m

Dec 31 2018US$6mUS$650k

US$29m

Sep 30 2018n/an/a

US$86m

Jun 30 2018n/an/a

US$86m

Mar 31 2018n/an/a

US$18m

Dec 31 2017US$4mUS$650k

US$69m

Rémunération vs marché: La rémunération totale de Vivek ($USD 6.81M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 6.57M ).

Rémunération et revenus: La rémunération de Vivek a augmenté alors que l'entreprise n'est pas rentable.


PDG

Vivek Jain (52 yo)

10.8yrs

Titularisation

US$6,810,975

Compensation

Mr. Vivek Jain has been an Independent Director of Envista Holdings Corporation since April 07, 2020. Mr. Jain has been Chairman and Chief Executive Officer of ICU Medical, Inc. since February 13, 2014. Mr...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Vivek Jain
CEO & Chairman of the Board10.8yrsUS$6.81m0.79%
$ 32.4m
Daniel Woolson
Presidentless than a yearUS$2.21m0.054%
$ 2.2m
Brian Bonnell
CFO & Treasurer4.7yrsUS$4.39m0.10%
$ 4.2m
Christian Voigtlander
Chief Operating Officer6.8yrsUS$4.40mpas de données
Virginia Sanzone
Corporate VP6.8yrsUS$2.47m0.018%
$ 751.3k

6.8yrs

Durée moyenne de l'emploi

50yo

Âge moyen

Gestion expérimentée: L'équipe dirigeante de ICUI est chevronnée et expérimentée (6.8 années d'ancienneté moyenne).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Vivek Jain
CEO & Chairman of the Board10.8yrsUS$6.81m0.79%
$ 32.4m
Elisha Finney
Independent Director8.8yrsUS$265.14k0.0087%
$ 357.0k
Kolleen Kennedy
Independent Director2.9yrsUS$255.14k0.0064%
$ 261.8k
David Hoffmeister
Independent Director6.8yrsUS$282.14k0.012%
$ 507.2k
Laurie Hernandez
Independent Director3.3yrsUS$255.14k0.0077%
$ 316.0k
David Greenberg
Lead Independent Director9.3yrsUS$296.14k0.023%
$ 927.8k
Donald Abbey
Independent Director6.8yrsUS$255.14k0.012%
$ 507.2k

6.8yrs

Durée moyenne de l'emploi

63yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de ICUI sont considérés comme expérimentés (ancienneté moyenne 6.8 ans).